SCHEMBL9604216

SCHEMBL9604216

COc1ccc(NCC(C)(C)C)c(N)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.44
MAPT P10636 5/20 0.44
MEN1 O00255 3/20 0.44
THRB P10828 3/20 0.44
KMT2A Q03164 3/20 0.44
GAA P10253 5/20 0.43
KDM4E B2RXH2 3/20 0.43
TDP1 Q9NUW8 3/20 0.43
RECQL P46063 2/20 0.43
BLM P54132 1/20 0.43
MCL1 Q07820 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CYP3A4 P08684 2/20 0.41
EGFR P00533 1/20 0.39
SCN2A Q99250 1/20 0.38
GRM2 Q14416 1/20 0.36
PTGER4 P35408 1/20 0.36
NPC1 O15118 1/20 0.36
GFER P55789 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12933389 0.81 GAA (0.50) ALDH1A1MAPTMEN1KMT2AGAA
SCHEMBL8348984 0.81 ALDH1A1 (0.51) ALDH1A1MAPTMEN1THRBKMT2A
SCHEMBL5697163 0.79 ALDH1A1 (0.50) ALDH1A1MAPTMEN1THRBKMT2A
SCHEMBL29703916 0.78 ALDH1A1 (0.53) ALDH1A1MAPTMEN1THRBKMT2A
SCHEMBL431525 0.78 ALDH1A1 (0.53) ALDH1A1MAPTMEN1THRBKMT2A
SCHEMBL29703915 0.78 ALDH1A1 (0.53) ALDH1A1MAPTMEN1THRBKMT2A
Hydrochloric Acid SCHEMBL11039565 0.77 ALDH1A1 (0.57) ALDH1A1MAPTMEN1THRBKMT2A
SCHEMBL8371590 0.77 ALDH1A1 (0.47) ALDH1A1MAPTMEN1THRBKMT2A
SCHEMBL12933392 0.76 RAB9A (0.40) ALDH1A1MAPTMEN1KMT2AGAA
SCHEMBL8611589 0.76 CYP3A4 (0.42) ALDH1A1MAPTTHRBKMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8975286-B2 Ether benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2015-03-10 US disclosed
US-8975286-B2 Ether benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2015-03-10 US disclosed
US-8785481-B2 Ether benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2014-07-22 US disclosed
US-8785481-B2 Ether benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2014-07-22 US disclosed
US-20120149677-A1 ETHER BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME LLC 2012-06-14 US disclosed
US-20120149677-A1 ETHER BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME LLC 2012-06-14 US disclosed
US-20120135977-A1 ETHER BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME LLC 2012-05-31 US disclosed
US-20120135977-A1 ETHER BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME LLC 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149677-A1 ETHER BENZOTRIAZOLE DERIVATIVES GRM2, GRIA2, GRIK2 ALDH1A1 3327/4885MAPT 362/4885MEN1 4800/4885
US-20120135977-A1 ETHER BENZOTRIAZOLE DERIVATIVES GRM2, GRIA2, GRIK2 ALDH1A1 3327/4885MAPT 362/4885MEN1 4800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.